Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	910	1,076	806	128	54	63
Market Cap Growth	26.50%	33.55%	528.00%	138.81%	-14.90%	-4.70%
Enterprise Value	896	1,063	793	114	34	38
Last Close Price	23.24	27.48	21.35	3.49	1.47	1.93
PE Ratio	450.08	531.92	-	-	-	-
PS Ratio	7.86	9.29	10.44	3.82	2.99	4.57
PB Ratio	13.59	16.06	13.80	2.26	0.78	0.82
P/TBV Ratio	26.34	31.13	33.33	8.15	2.67	3.01
P/FCF Ratio	-	-	385.54	-	-	-
P/OCF Ratio	-	-	251.14	-	-	-
EV/Sales Ratio	7.74	9.18	10.28	3.41	1.90	2.77
EV/EBITDA Ratio	91.79	116.34	377.84	-	-	-
EV/EBIT Ratio	126.25	149.76	7295.50	-	-	-
EV/FCF Ratio	-390.39	-	379.64	-	-	-
Debt / Equity Ratio	0.02	0.02	0.03	0.04	0.03	0.03
Debt / EBITDA Ratio	0.11	0.11	0.64	-	-	-
Debt / FCF Ratio	-	-	0.85	-	-	-
Net Debt / Equity Ratio	-0.22	-0.22	-0.28	-0.21	-0.32	-0.34
Net Debt / EBITDA Ratio	-1.59	-1.59	-7.68	4.04	2.95	4.17
Net Debt / FCF Ratio	6.35	6.35	-7.72	1.32	2.86	4.58
Asset Turnover	1.29	1.29	0.99	0.44	0.21	0.15
Inventory Turnover	1.17	1.17	1.21	1.27	1.47	2.33
Quick Ratio	1.42	1.42	1.64	2.22	2.20	2.72
Current Ratio	1.96	1.96	2.14	2.77	2.49	2.91
Return on Equity (ROE)	3.31%	3.31%	-6.59%	-16.18%	-20.02%	-9.33%
Return on Assets (ROA)	4.94%	4.94%	0.09%	-4.12%	-7.06%	-5.90%
Return on Invested Capital (ROIC)	6.65%	7.80%	0.24%	-11.67%	-20.09%	-15.80%
Return on Capital Employed (ROCE)	9.80%	9.80%	0.20%	-8.20%	-14.00%	-11.00%
Earnings Yield	0.22%	0.19%	-0.54%	-10.70%	-27.17%	-11.95%
FCF Yield	-0.25%	-0.21%	0.26%	-7.14%	-14.41%	-9.13%
Buyback Yield / Dilution	-11.26%	-11.26%	-1.69%	-7.91%	-3.37%	-34.86%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.